Clinical Survival Prediction Tools for Neuro-Oncology
[ Download on the App Store ]
NeNo (Neurosurgery Nomogram) provides individualized survival estimates for patients with selected brain and nervous system tumors using patient, tumor, and treatment characteristics.
About the Models
Source
Surveillance, Epidemiology, and End Results (SEER) database
2000–2023
Tumor Models
Astrocytoma
Ependymoma
Ethesioneuroblastoma
Glioma
Glioblastoma
Medulloblastoma
Meningioma
Oligodendroglioma
Pilocytic astrocytoma
Pleomorphic xanthoastrocytoma
Posterior fossa glioblastoma
Schwannoma
User Display Features
Individualized survival prediction is conducted at user-defined timepoints from 0-120 months.
Internal Validation: 500 sample bootstrapping with optimism-corrected calibration.
Temporal Validation: 80% training and 20% testing cohort split chronologically.
Kaplan-Meier curves for significant univariate variables.
Forest plot representing multivariable analysis.
Receiver Operator Characteristics curve, Area Under the Curve, Brier Scores, Calibration plot.
Medical Disclaimer
NeNo is intended for research and educational purposes and is not intended to replace professional medical advice, diagnosis, or treatment. Survival estimates are based on statistical models derived from population-level data and should not be used as the sole basis for clinical decision-making. Further, estimates do not guarantee individual outcomes.